1997 Volume 18 Issue 4 Pages 61-65
Advances in three main factors, which are photosensitizers, laser equipments and fluorescence detectors, develope photodynamic diagnosis and therapy in the fields of canser research and vascular medicine. A new photosensitizer, mono-L-aspartyl chlorin e6 (NPe6), accumulates in atheroma and emitts fluorescence at 672nm by irradiation of laser at 664nm. Atheroma is diagnosed using the high sensitive fluorescence detector with a selective band pass filter and treated by laser irradiation with high tissue fluence. Indication of photodynamic diagnosis and therapy now spreads to the atherosclerotic diseases.